Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Zostavax in Patients With Systemic Lupus Erythematosus
NCT02477150Phase 4Completed
- Sponsor
- Tuen Mun Hospital
- Start
- Nov 2015
- Primary completion
- Nov 2018
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by Tuen Mun Hospital. Started Nov 2015; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02477150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477150.